Prospective Cohort Study Comparing Spirometry, Asthma Control Test, and Fractional Exhaled Nitric Oxide in Predicting Asthma Exacerbations in a Tertiary Care Hospital

Abstract Background: Asthma is a chronic airway disease that causes patients to experience breathing difficulties together with restricted airflow. The disease causes patients to experience acute exacerbations which lead to increased healthcare costs and higher levels of illness. The current methods of predicting asthma exacerbations through symptom assessment and lung function tests face substantial difficulties. Objectives: To assess the ability of fractional exhaled nitric oxide (FeNO) in predicting future exacerbations of Asthma. To assess and compare the ability of FeNO, spirometry, and the Asthma Control Test (ACT) in predicting future exacerbations of asthma and their correlation with each other. Materials and Methods: A prospective cohort study was conducted among 86 individuals with bronchial asthma at a tertiary care center. Assessment at baseline included ACT scoring, spirometry, and FeNO levels. The patients were then followed up for the development of asthma exacerbations. The statistical analyses involved the Chi-square test and Mann–Whitney U test. P < 0.05 was used to determine statistical significance. Results: There were 26 (30.2%) cases of asthma exacerbation among the study population. Those with asthma exacerbations exhibited significantly lower ACT scores and lower Forced Expiratory Volume in one second (% predicted) values than those without exacerbations ( P < 0.001; P < 0.01, respectively). An increased level of FeNO was strongly correlated with an increased risk of future asthma exacerbations, and those with FeNO > 50 ppb were at the highest risk ( P < 0.001). In comparison with the other two assessment techniques, FeNO proved to have higher predictive value than the ACT score and spirometry parameters. Conclusion: FeNO is a strong and independent predictor of future asthma exacerbations. The combination of symptom-based assessment and spirometry fails to provide reliable prediction of exacerbation risk. The combined assessment method, which includes ACT and spirometry and FeNO measurement, establishes an asthma risk assessment and management method that offers complete and precise results.

Authors

Institutions

Publication Details

Journal
Annals of African Medicine
Published
2026-11-16
DOI
https://doi.org/10.4103/aam.aam_713_26
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prospective Cohort Study Comparing Spirometry, Asthma Control Test, and Fractional Exhaled Nitric Oxide in Predicting Asthma Exacerbations in a Tertiary Care Hospital

V. Jereen, D. L. Sam Bennihin, Moniish Venkatesan, Gurrammagari Naga Rohith et al.
1 links
Annals of African Medicine
Asthma and respiratory diseases
article

Prospective Cohort Study Comparing Spirometry, Asthma Control Test, and Fractional Exhaled Nitric Oxide in Predicting Asthma Exacerbations in a Tertiary Care Hospital

V. Jereen, D. L. Sam Bennihin, Moniish Venkatesan, Gurrammagari Naga Rohith, Siva Santha Kumar
article en

Abstract

Abstract Background: Asthma is a chronic airway disease that causes patients to experience breathing difficulties together with restricted airflow. The disease causes patients to experience acute exacerbations which lead to increased healthcare costs and higher levels of illness. The current methods of predicting asthma exacerbations through symptom assessment and lung function tests face substantial difficulties. Objectives: To assess the ability of fractional exhaled nitric oxide (FeNO) in predicting future exacerbations of Asthma. To assess and compare the ability of FeNO, spirometry, and the Asthma Control Test (ACT) in predicting future exacerbations of asthma and their correlation with each other. Materials and Methods: A prospective cohort study was conducted among 86 individuals with bronchial asthma at a tertiary care center. Assessment at baseline included ACT scoring, spirometry, and FeNO levels. The patients were then followed up for the development of asthma exacerbations. The statistical analyses involved the Chi-square test and Mann–Whitney U test. P < 0.05 was used to determine statistical significance. Results: There were 26 (30.2%) cases of asthma exacerbation among the study population. Those with asthma exacerbations exhibited significantly lower ACT scores and lower Forced Expiratory Volume in one second (% predicted) values than those without exacerbations ( P < 0.001; P < 0.01, respectively). An increased level of FeNO was strongly correlated with an increased risk of future asthma exacerbations, and those with FeNO > 50 ppb were at the highest risk ( P < 0.001). In comparison with the other two assessment techniques, FeNO proved to have higher predictive value than the ACT score and spirometry parameters. Conclusion: FeNO is a strong and independent predictor of future asthma exacerbations. The combination of symptom-based assessment and spirometry fails to provide reliable prediction of exacerbation risk. The combined assessment method, which includes ACT and spirometry and FeNO measurement, establishes an asthma risk assessment and management method that offers complete and precise results.

Annals of African Medicine
Shri Sathya Sai Medical College and Research Institute (IN), Sri Balaji Vidyapeeth University (IN)
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon